We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRVC
626
DELISTED
MRV Communications Inc
MRVC
$1.15M 0.01%
+79,093
New +$1.16M
KMI icon
627
Kinder Morgan
KMI
$70.6B
$1.14M 0.01%
35,189
+23,758
+208% +$796K
EMBJ
628
Embraer S.A. ADS
EMBJ
$12.1B
$1.13M 0.01%
31,859
+3,376
+12% +$113K
NBL
629
DELISTED
Noble Energy, Inc.
NBL
$1.13M 0.01%
15,846
-3,743
-19% -$248K
CHL
630
DELISTED
China Mobile Limited
CHL
$1.12M 0.01%
24,610
+2,344
+11% +$111K
CAKE icon
631
Cheesecake Factory
CAKE
$4.32B
$1.1M 0.01%
23,122
+12,742
+123% +$594K
BMRN icon
632
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.1M 0.01%
16,100
+4,400
+38% +$324K
COR
633
DELISTED
Coresite Realty Corporation
COR
$1.1M 0.01%
35,360
+17,900
+103% +$559K
AME icon
634
Ametek
AME
$55.7B
$1.09M 0.01%
21,164
+4,400
+26% +$228K
BIDU icon
635
Baidu
BIDU
$35.8B
$1.09M 0.01%
7,154
+1,030
+17% +$172K
VGT icon
636
Vanguard Information Technology ETF
VGT
$138B
$1.07M 0.01%
93,440
+9,600
+11% +$108K
GNC
637
DELISTED
GNC Holdings, Inc.
GNC
$1.05M 0.01%
23,844
+22,719
+2,019% +$1.12M
CINF icon
638
Cincinnati Financial
CINF
$28.5B
$1.04M 0.01%
21,435
-75
-0.3% -$3.62K
WAFD icon
639
WaFd
WAFD
$2.69B
$1.04M 0.01%
44,480
+27,300
+159% +$619K
PRXL
640
DELISTED
Parexel International Corp
PRXL
$1.03M 0.01%
19,102
-1,042
-5% -$53.4K
MIDD icon
641
Middleby
MIDD
$6.15B
$1.03M 0.01%
11,706
-1,467
-11% -$128K
WPP icon
642
WPP
WPP
$4.21B
$1.03M 0.01%
10,000
PNW icon
643
Pinnacle West Capital
PNW
$12.8B
$1.02M 0.01%
18,758
-157
-0.8% -$8.41K
UL icon
644
Unilever
UL
$132B
$1.02M 0.01%
21,213
+1,164
+6% +$52.5K
WOR icon
645
Worthington Enterprises
WOR
$2.79B
$1.02M 0.01%
43,267
+8,644
+25% +$215K
NOW icon
646
ServiceNow
NOW
$109B
$1.01M 0.01%
84,545
+775
+0.9% +$9.86K
AAXJ icon
647
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.66B
$1.01M 0.01%
17,040
+19
+0.1% +$1.09K
ENLK
648
DELISTED
EnLink Midstream Partners, LP
ENLK
$1M 0.01%
32,875
RRC icon
649
Range Resources
RRC
$8.85B
$999K 0.01%
12,055
-10
-0.1% -$851
RDS.B
650
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$998K 0.01%
12,787
-25
-0.2% -$1.9K

Similar funds

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.